 |
28bio
Last updated: August 07, 2025
Founders: Lowry Curley, Michael Moore
USA | Funding: $15.7M (+)
Website: https://www.28bio.com
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
Website: https://www.28bio.com
28bio's Nerve-on-a-Chip platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
